Learn

GLP-1 side effects, from the labels.

What the semaglutide and tirzepatide prescribing information actually reports, quoted and dated, and how to keep a record of your own.

GLP-1 nausea: how common it is, and keeping track of itNausea is the most commonly reported side effect of semaglutide and tirzepatide in the weight-loss trials, mostly while the dose was being increased. What the labels report, and how to keep a record of yours.GLP-1 diarrhea and constipation: what the labels reportBoth are common on semaglutide and tirzepatide. The trial rates from each label, when they tend to happen, and what the labels say about fluids.GLP-1 burping, "sulfur burps" and refluxBurping (eructation) and reflux are listed side effects of semaglutide and tirzepatide. The label rates, and a simple way to keep track.GLP-1 injection site reactions, and rotating sitesRedness, itching, bruising or pain where you inject. How often the labels report it for semaglutide and tirzepatide, and keeping track of where you injected.Hair loss on GLP-1s: what the labels sayHair loss is a listed side effect of both semaglutide and tirzepatide, and the Zepbound label links it to weight reduction. The figures, including the difference between women and men.Tiredness and dizziness on GLP-1sFatigue and dizziness are listed side effects of semaglutide and tirzepatide. What the labels report, and what they connect them to.Missed a GLP-1 dose? What the labels sayEach GLP-1 has its own missed-dose instructions in its prescribing information. What the Wegovy and Zepbound labels say, word for word, and how to avoid missing the next one.When GLP-1 side effects happen, and how often people stopMost stomach side effects on semaglutide and tirzepatide were reported while the dose was being increased. What the labels say about timing, and how many people stopped treatment because of them.

Next

Keep your own record.

Doses, sites, journal and weight on one timeline. Thirty days free.